SenzaGen AB (OSTO:SENZA) Cash Flow from Others : kr13.01 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is SenzaGen AB Cash Flow from Others?

SenzaGen AB's cash flow from others for the three months ended in Dec. 2024 was kr2.52 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was kr13.01 Mil.

SenzaGen AB Cash Flow from Others Historical Data

The historical data trend for SenzaGen AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenzaGen AB Cash Flow from Others Chart

SenzaGen AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

0.56

0.01

0.22

-0.18

2.79

SenzaGen AB Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow from Others	Get a 7-Day Free Trial															2.89	2.93	5.03	2.54	2.52

SenzaGen AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.01 Mil.

SenzaGen AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of SenzaGen AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

SenzaGen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Building 401, Lund, SWE, 223 81

Website

https://www.senzagen.com

SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.

SenzaGen AB Headlines

No Headlines